Compounds of Formula I ##STR1## are disclosed as inhibitors having {HEAD ~ activity} against {TAIL ~ the aspartyl proteases}, plasmepsin and cathepsin D. The compounds are therefore useful for treatment of diseases such as malaria and Alzheimers disease 
against
Compounds of Formula I # # STR1 # # are disclosed as inhibitors having { HEAD ~ activity } against { TAIL ~ the aspartyl proteases } , plasmepsin and cathepsin D. The compounds are therefore useful for treatment of diseases such as malaria and Alzheimers disease
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD REL TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH